Renaissance Capital logo

Tilray Priced, Nasdaq: TLRY

Canadian vertically integrated supplier of medical and recreational cannabis.

Industry: Consumer Discretionary

Latest Trade: $9.10 0.00 (0.0%)

First Day Return: +31.7%

Return from IPO: -46.5%

Industry: Consumer Discretionary

We have been an early leader in the development of the global medical cannabis market. We were one of the first companies to be licensed by Health Canada to cultivate and sell medical cannabis in Canada, and also one of the first companies to become a licensed dealer of medical cannabis in Canada. The cannabis industry is rapidly expanding in Canada, with more than 100 other companies that are currently licensed, though only a few were licensed earlier than us, and there are hundreds more applications for licenses that are being processed by Health Canada. Our products have been made available in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand and South Africa. While there are others licensed to cultivate and sell medical cannabis operating in multiple countries, including some licensed in Canada, and other non-cannabis companies expanding into the cannabis market internationally, we were the first company to legally export medical cannabis from North America to Africa, Australia, Europe and South America, and we were among the first companies to be licensed to cultivate and process medical cannabis in two countries, Canada and Portugal.
more less
IPO News for Tilray
more
IPO Data
IPO File Date 06/20/2018
Offer Price $17.00
Price Range $14.00 - $16.00
Offer Shares (mm) 9.0
Deal Size ($mm) $153
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 07/18/2018
Offer Price $17.00
Price Range $14.00 - $16.00
Offer Shares (mm) 9.0
Deal Size ($mm) $153
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Nanaimo, Canada
Founded 2013
Employees 330
Website www.tilray.com